A global collaboration to expand access to advanced particle therapy worldwide was agreed this April between Belgian firm IBA (Ion Beam Applications S.A.) and the Toshiba Corporation.
Bio-Rad Laboratories, a global provider of life science research and clinical diagnostic products, announced that Bio-Rad is extending its agreement with Beckman Coulter and has named the company exclusive global distributor of Bio-Rad's Access HIV combo assay and the Access hepatitis C virus (HCV) assay in select geographies.
Toshiba Medical Systems Europe today announced that it has signed a European Union-wide reseller agreement with French radiology manufacturer, Apelem, to market Xantara, a remote controlled, digital radiography and fluoroscopy (RF) system developed for Toshiba Medical Systems Europe.
Imec, Medtronic, Ghent University and their project partners today announced the launch of the CARDIS project. Together they will develop and validate an early-stage cardio vascular disease detection platform using integrated silicon photonics.
Heraeus Medical GmbH announced today an agreement with Locate Therapeutics to license the intellectual property surrounding the use of Taos in orthopaedic applications and the inception of the first development program in this field.
Andalusia Health Service has selected Accenture and Carestream Health to deploy a picture archiving and communications system (PACS) that will allow clinicians to manage, store and share diagnostic imaging data across more than 1,600 healthcare facilities in Spain. This initiative by the Andalusia Health Service is expected to go live in late 2015, creating one of the largest medical imaging…
Carestream Health announces cooperation with MSC Cruises and Italy’s Gaslini Institute in Genoa, Italy. As part of this collaborative effort, Carestream will be providing a cloud-based teleconsultation portal to enable the Institute to deliver remote diagnosis, specialist second opinions, patient monitoring and referrals wherever needed at any time.
Radiology will be in the spotlight on November 8, as radiologists celebrate the International Day of Radiology (IDoR) through a series of events and information campaigns to help the public better understand the role of medical imaging in healthcare.
Beckman Coulter, an indirect wholly-owned subsidiary of Danaher Corporation (NYSE:DHR), announced today that it has entered into a definitive agreement to purchase the clinical microbiology business of Siemens Healthcare Diagnostics.
Even a giant must learn to walk by taking small steps first. Founded in 1998, and as a wholly-owned subsidiary of Neusoft Corporation, Neusoft Medical has moved deliberately to build its strengths, becoming the premier developer and manufacturer of advanced medical equipment in China – and the first in that country capable of building a computed tomography (CT) scanner.
Royal Philips today announced that it has signed a partnership agreement with the Stockholm County Council (SCC) to jointly innovate in health care.
Bayer has agreed to acquire the consumer care business of U.S. pharmaceutical company Merck & Co., Inc., Whitehouse Station, NJ, USA, for a purchase price of USD 14.2 billion (EUR 10.4 billion).
Over the next few years, the University Medical Center (UMC) Utrecht and Quirem Medical will be working closely together to maximize the benefits of using holmium microspheres to treat liver cancer patients worldwide.
On March 6, COCIR* and ESR held a Joint Session at 2014 European Congress of Radiology (ECR) entitled “How does integrity affect our daily lives? A joint radiologist/industry initiative”.
Today, more than fifty percent of all ultrasound examinations are not performed by radiologists,” underlines Professor Dr Lorenzo Derchi, Head of Emergency Radiology at San Martino Hospital at University Hospital Genoa in Italy.
Curie-Cancer, the body which leads the Institut Curie's industry partner research activity, and Servier, today announce that they have renewed their partnership with the aim of identifying therapeutic targets for treating ‘triple negative’ breast cancers. The partnership will continue for a further three years.
Partnerships are at the top of the agenda for RSNA 2013. To meet current and emerging challenges, “we need internal partnerships within radiology and external ones with our clinical peers as well as with our patients,” outlined Sarah S. Donaldson, MD in her opening address of the 99th RSNA Scientific Assembly and Annual Meeting.
Fast, secure telemedicine solution delivers HD visual teleconsultation to hundreds of healthcare organizations worldwide
Born in the USA out of the anthrax scare that followed the 9/11 attacks, the formation of a network of laboratories kept on 24/7 alert against potential bio-terrorism was introduced in France at the end of 2001.
Prostate cancer is the most common cancerous disease in men. Since magnetic resonance imaging (MRI) arrived the diagnostic capabilities for early detection have improved considerably, along with more selective prostate cancer treatment.
Royal Philips Electronics and Sectra today announced an agreement to extend the term of their existing PACS support partnership agreement. This agreement allows Philips to provide continued support for Sectra PACS installations through 2020, and can be extended on a yearly basis thereafter.
Cooperation between the individual diagnostic fields of radiology, pathology and laboratory medicine has increased in daily clinical routine over the last few years. To a large extent, the three disciplines are faced with the same requirements and problems.
Samsung BioLogics today announced that Samsung BioLogics and F. Hoffmann-La Roche have entered into a long term strategic manufacturing agreement under which Samsung will manufacture Roche's proprietary commercial biologic medicines at its two manufacturing facilities in Incheon, South Korea, of which one is currently under construction.
Run by Sheffield Teaching Hospitals NHS Trust, the new automated Medical Laboratory at the Northern General Hospital has drawn a previously fragmented service into a purpose-built centre.
Sanofi and the Curie Institute, through its Curie-Cancer partnership under the Institut Carnot label, today announce the establishment of a three-year research collaboration to identify new therapeutic targets for the development of treatments for ovarian cancer.
